Roche makes diagnostics headway with Bina Technologies acquisition

Roche ($RHHBY) is decking the halls with diagnostics acquisitions and Bina Technologies is the company's latest target. The Swiss company snatched up the DNA sequencing outfit for an undisclosed sum, getting its hands on Bina's Genomic Management Solution system, a next-generation tool that helps cut down time and costs associated with genomic sequencing. Roche will integrate the Redwood City, CA-based company into its Sequencing Unit and plans to work with Bina to beef up R&D and commercialization for its analytic tool. More from FierceMedicalDevices

Suggested Articles

The Rady Children’s Institute for Genomic Medicine tapped Deloitte to help develop a network of flying drones to deliver genetic testing specimens.

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart.

The respiratory care company Vyaire Medical has brought on a new CEO, Gaurav Agarwal, following a year of new product launches.